These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31455548)

  • 21. Association between the 8-item Morisky medication adherence scale (MMAS-8) score and glycaemic control among Chinese diabetes patients.
    Wong MC; Wu CH; Wang HH; Li HW; Hui EM; Lam AT; Chung RY; Yip BH; Morisky DE
    J Clin Pharmacol; 2015 Mar; 55(3):279-87. PubMed ID: 25293349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
    Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycated haemoglobin A
    Rathod SD; Crampin AC; Musicha C; Kayuni N; Banda L; Saul J; McLean E; Branson K; Jaffar S; Nyirenda MJ
    BMJ Open; 2018 May; 8(5):e020972. PubMed ID: 29730628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An additional measurement of glycated albumin can help prevent missed diagnosis of diabetes in Chinese population.
    He X; Ying L; Ma X; Shen Y; Su H; Peng J; Wang Y; Bao Y; Zhou J; Jia W
    Clin Chim Acta; 2017 Dec; 475():188-192. PubMed ID: 29061312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline HbA1c predicts attainment of 7.0% HbA1c target with structured titration of insulin glargine in type 2 diabetes: a patient-level analysis of 12 studies.
    Riddle MC; Vlajnic A; Zhou R; Rosenstock J
    Diabetes Obes Metab; 2013 Sep; 15(9):819-25. PubMed ID: 23489438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the quality of life among patients with diabetes in Austria and the correlation between glycemic control and the quality of life.
    Al-Taie N; Maftei D; Kautzky-Willer A; Krebs M; Stingl H
    Prim Care Diabetes; 2020 Apr; 14(2):133-138. PubMed ID: 31859064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
    Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetes mellitus: how well controlled in our patients?
    Ahmed N; Jadoon SA; Khan RM; Mazahar-Ud-Duha ; Javed M
    J Ayub Med Coll Abbottabad; 2008; 20(4):70-2. PubMed ID: 19999209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.
    Luo M; Kong X; Wang H; Zhai X; Cai T; Ding B; Hu Y; Jing T; Su X; Li H; Ma J
    J Diabetes Res; 2020; 2020():6666403. PubMed ID: 33299890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethnic disparities in glycemic control among rural older adults with type 2 diabetes.
    Quandt SA; Bell RA; Snively BM; Smith SL; Stafford JM; Wetmore LK; Arcury TA
    Ethn Dis; 2005; 15(4):656-63. PubMed ID: 16259490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.
    Munkhaugen J; Hjelmesæth J; Otterstad JE; Helseth R; Sollid ST; Gjertsen E; Gullestad L; Perk J; Moum T; Husebye E; Dammen T
    BMC Cardiovasc Disord; 2018 Aug; 18(1):160. PubMed ID: 30075751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention.
    Nusca A; Tuccinardi D; Proscia C; Melfi R; Manfrini S; Nicolucci A; Ceriello A; Pozzilli P; Ussia GP; Grigioni F; Di Sciascio G
    Cardiovasc Diabetol; 2019 Nov; 18(1):147. PubMed ID: 31706305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in Asian patients with diabetes: The Registry for Assessing OAD Usage in Diabetes Management (REASON) Asia study.
    Vichayanrat A; Matawaran BJ; Wibudi A; Ferdous HS; Aamir AH; Aggarwal SK; Bajpai S
    J Diabetes; 2013 Sep; 5(3):309-18. PubMed ID: 23462227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease.
    Sara JD; Taher R; Kolluri N; Vella A; Lerman LO; Lerman A
    Cardiovasc Diabetol; 2019 Feb; 18(1):22. PubMed ID: 30819191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive lifestyle intervention is particularly advantageous in poorly controlled type 2 diabetes.
    Sbroma Tomaro E; Pippi R; Reginato E; Aiello C; Buratta L; Mazzeschi C; Perrone C; Ranucci C; Tirimagni A; Russo A; Fatone C; Fanelli C; De Feo P
    Nutr Metab Cardiovasc Dis; 2017 Aug; 27(8):688-694. PubMed ID: 28735815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial.
    van Dieren S; Kengne AP; Chalmers J; Beulens JW; Davis TM; Fulcher G; Heller SR; Patel A; Colagiuri S; Hamet P; Mancia G; Marre M; Neal B; Williams B; Peelen LM; van der Schouw YT; Woodward M; Zoungas S
    Diabetes Obes Metab; 2014 May; 16(5):426-32. PubMed ID: 24251579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral arterial disease and type 2 diabetes: Older patients still exhibit a survival benefit from glucose control.
    Höbaus C; Herz CT; Wrba T; Koppensteiner R; Schernthaner GH
    Diab Vasc Dis Res; 2020; 17(2):1479164120914845. PubMed ID: 32308023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
    Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.